Message from Deputy Director

I have served as Deputy Director of the Department of Development Promotion since July 2012. Before joining the department, I spent about ten years at the Pharmaceuticals and Medical Devices Agency (PMDA) engaged in medical device review. Looking back, my time here has now exceeded my years at PMDA, reminding me how quickly time passes. When I first joined, the department was small and supported only a limited number of development seeds. Today, it has grown into an organization of nearly thirty professionals dedicated to helping researchers and companies advance innovative technologies toward practical application. Despite this growth, our guiding principles remain unchanged: balance and optimization. Many academic seeds are based on novel technologies and address unmet medical needs, making it difficult to rely solely on past experience. Bringing them into practice requires carefully balancing safety and efficacy, particularly when they are used in humans for the first time. The foundation for this approach is regulatory science, which helps us make evidence-based decisions and optimize innovation in harmony with societal needs. We believe the future of healthcare depends on individuals who can think flexibly, look beyond precedent, and create new medical innovations. Our department will continue working to bring innovative pharmaceuticals and medical devices to society while fostering the next generation of leaders in medical innovation.
March 2026
Koji Ikeda
Department of Development Promotion
Supporting startups from inception to exit
The Department of Development Promotion serves as the entry point for all seeds seeking support from the Clinical Research, Innovation and Education Center, including those from both within and outside Tohoku University. We coordinate support activities across the Center through seed intake, progress management, and consultation on non-clinical studies.
Our primary role is to help formulate appropriate development strategies based on scientific evidence and regulatory requirements. Leveraging expertise from members with experience at PMDA, MHLW, and AMED, we provide regulatory-informed guidance throughout the development process.
By establishing efficient and effective development pathways, we support the achievement of key goals such as industry licensing, transition to advanced medical care programs, regulatory approval, and startup creation. For startup-oriented projects, we work closely with the Medical Startup Facilitation Office.

Medical Startup Facilitation Office
Supporting startups from pre‑launch to exit

The Medical Startup Facilitation Office provides comprehensive support for medical startups at every stage, from pre-incorporation planning to commercialization and exit. Working closely with the Department of Development Promotion and other university partners, as well as external stakeholders including venture capital firms, companies, government agencies, and international support organizations, we help startups navigate growth and development.
Our support includes startup planning, business strategy development, fundraising, and commercialization support. By taking a broad view of the entire development pathway, we work alongside founders to design and implement effective strategies for success.
Our mission is to ensure that medical innovations reach patients through successful social implementation and to advance globally impactful medical innovation rooted in academic research.
